1 domain / 2 areas / 1 specialization
Cantor Fitzgerald
Data updated
Cantor Fitzgerald is a global financial services firm founded in 1945 that provides investment banking, capital markets, fixed income, equities, prime services, research, asset management, and related services. Its website identifies it as a privately owned firm with a broad institutional and public-markets orientation, and its headquarters is in New York, New York, United States.
For the psychedelic ecosystem, Cantor Fitzgerald appears relevant mainly as a capital-markets and financing intermediary rather than a dedicated psychedelic investor. Public materials show activity in investment banking, SPACs, PIPE placements, and asset management, which can make it relevant to public psychedelic companies seeking listings, financings, or coverage, but there is no public evidence of a specific psychedelic focus.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
Cantor Fitzgerald is best characterized as a large, multi-vertical financial services platform with institutional distribution, investment banking, asset management, and public-markets capabilities. Its public materials emphasize broad capital formation and market-access services rather than a sector-specific thesis, so its relevance to psychedelics is primarily as a potential financing or market-structure participant for public companies in the space, not as a specialist thematic backer.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 1945
- HQ
- New York, NY, United States
- Website
- Visit